Zeesan

Zeesan Biotech, established in 2010, is a prominent player in the biomedical sector, focusing on the development and production of advanced molecular diagnostic testing kits and instruments. Operating within the Medical Devices & Equipment and Manufacturing industries, the company leverages a decade of experience to provide innovative solutions for healthcare providers and laboratories. Zeesan's core mission revolves around advancing molecular diagnostics technology to improve disease detection and identification. The company's product portfolio is extensive, featuring nucleic acid extraction kits, specialized molecular diagnostic kits for critical diseases such as tuberculosis, HPV, and leukemia, alongside automated systems designed for efficient sample processing. This commitment to technological advancement is driven by a dedicated team, and you can Meet Zeesan's team to learn more about the expertise behind their innovations. With an employee range of 500-1,000 individuals, Zeesan operates with significant capacity to meet market demands. The company generates an annual revenue of $44.0M, positioning it as a notable entity within its competitive landscape. Zeesan's strategic focus on technology-driven molecular diagnostics ensures it remains at the forefront of the field, contributing essential tools for accurate and timely medical assessments. Its presence in the market is further solidified by its B2B focus and its commitment to quality manufacturing.